NCBI Taxonomy: 31391

Polyneura latissima (ncbi_taxid: 31391)

found 14 associated metabolites at species taxonomy rank level.

Ancestor: Polyneura

Child Taxonomies: none taxonomy data.

9-HETE

(5Z,7E,11Z,14Z)-(9S)-9-Hydroxyeicosa-5,7,11,14-tetraenoic acid

C20H32O3 (320.2351322)


9-HETE, which is a product of free radical-mediated arachidonic acid oxidation, is significantly elevated in patients with angiographically defined CAD. (PMID: 17145556). 9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. [HMDB] 9-HETE, which is a product of free radical-mediated arachidonic acid oxidation, is significantly elevated in patients with angiographically defined CAD. (PMID: 17145556). 9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid.

   

9S-HETE

(5Z,7E,11Z,14Z)-(9S)-9-Hydroxyeicosa-5,7,11,14-tetraenoic acid

C20H32O3 (320.23513219999995)


A HETE having a (9S)-hydroxy group and (5Z)-, (7E)-, (11Z)- and (14Z)-double bonds.

   

6-{[29-(2-hydroxy-3,5-dimethoxyphenyl)-10-({2-[5-(2-hydroxy-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl)oxolan-2-yl]-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl}oxy)nonacosan-9-yl]oxy}-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

6-{[29-(2-hydroxy-3,5-dimethoxyphenyl)-10-({2-[5-(2-hydroxy-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl)oxolan-2-yl]-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl}oxy)nonacosan-9-yl]oxy}-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C111H178O8 (1639.3520988)


   

6-{[31-(2-hydroxy-3,5-dimethoxyphenyl)-10-({2-[5-(2-hydroxy-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl)oxolan-2-yl]-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl}oxy)hentriacontan-9-yl]oxy}-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

6-{[31-(2-hydroxy-3,5-dimethoxyphenyl)-10-({2-[5-(2-hydroxy-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl)oxolan-2-yl]-5,9,10-trimethyl-6-methylideneundec-10-en-2-yl}oxy)hentriacontan-9-yl]oxy}-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C113H182O8 (1667.3833972)


   

(5z,7e)-8-[(1z,3z,6z)-dodeca-1,3,6-trien-1-yloxy]octa-5,7-dienoic acid

(5z,7e)-8-[(1z,3z,6z)-dodeca-1,3,6-trien-1-yloxy]octa-5,7-dienoic acid

C20H30O3 (318.21948299999997)


   

(5z,7s)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

(5z,7s)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

C20H32O4 (336.2300472)


   

(5z,7r)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

(5z,7r)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

C20H32O4 (336.2300472)